LCTX · Lineage Cell Therapeutics, Inc. · Proposed Sales
$0.77
-0.05 (-5.87%)
At close · Nov 20
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$195.26M
Shares
252.95M
Volume · Nov 20
2.04M
Avg daily vol (3M)
1.63M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Showing 1–2 of 2 filings
Key facts
CIK
876343
CUSIP
53566P109
13F (30d)
146 filings
122 filers
Visit website
Investor relations